Alexander Willemse, BioConnection CEO

With con­tract man­u­fac­tur­ing work in high de­mand, Nether­lands CD­MO lands new in­vest­ment

A Dutch CD­MO is look­ing to build up­on its suc­cess over the past few years, and a re­cent­ly-an­nounced in­vest­ment will pave the way.

An undis­closed in­vest­ment from Gimv, sup­port­ed by share­hold­ers Pharm­ing Group N.V. and Mibiton, will be used to ac­cel­er­ate Bio­Con­nec­tion’s pro­duc­tion ca­pac­i­ty, qual­i­ty con­trol and in­no­va­tion. Bio­Con­nec­tion will use Gimv’s life sci­ence net­work as fu­ture lever­age, the state­ment said.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.